The Board of Directors of the company in its meeting held today i.e., Saturday, November 08, 2025 has: considered and approved the unaudited standalone financial results of the company for the Second quarter and the half year ended on September 30, 2025 along with the Limited Review Report submitted by the Statutory Auditors. based on the recommendation of Nomination and Remuneration Committee - unanimously approved the appointment of Ms. Jasmin Kunal Tailor (DIN: 10794164) as an Additional Non-Executive Independent Director for a term of 3 (Three) consecutive years with effect from 9th November 2025 to 8th November 2028, subject to the subsequent approval of the shareholders of the company. noted the resignation of Ms. Hari Priya Yerukalapudi (DIN:09690829) from the office of Independent Director w.e.f the close of business hours of 8th November, 2025. based on the recommendation of Nomination and Remuneration Committee - revised the remuneration of Mr. Gaddam Venkata Ramana (DIN: 00031873), Managing Director of the Company, subject to the approval of the shareholders. based on the recommendation of Nomination and Remuneration Committee - revised the remuneration of Mr. Satyanarayana Raju Bhupathiraju (DIN:02697880), Whole Time Director and CFO of the Company, subject to the approval of the shareholders.
VINEETLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Vineet Laboratories, at its meeting on November 8, 2025, approved the unaudited standalone financial results for Q2 and the half-year ended September 30, 2025, along with the statutory auditors' limited review report. The board appointed Ms. Jasmin Kunal Tailor (DIN: 10794164) as an Additional Non-Executive Independent Director for a 3-year term from November 9, 2025 to November 8, 2028, subject to shareholder approval. Ms. Hari Priya Yerukalapudi (DIN: 09690829) resigned as Independent Director effective end of business on November 8, 2025. The board also revised the remuneration of Managing Director Mr. Gaddam Venkata Ramana and Whole Time Director & CFO Mr. Satyanarayana Raju Bhupathiraju, both subject to shareholder approval.
The board sees a one-for-one Independent Director change with no top-management exits, while proposed pay hikes for the MD and CFO will need shareholder approval at the next general meeting. Investors should watch for the detailed Q2 results and the shareholder vote on the revised managerial remuneration.